Qianyu Wang,Águeda Molinero-Fernandez,Qikun Wei,Xing Xuan,Åsa Konradsson-Geuken,María Cuartero,Gastón A Crespo
Abstract:Lactate is an important diagnostic and prognostic biomarker of several human pathological conditions, such as sepsis, malaria, and dengue fever. Unfortunately, due to the lack of reliable analytical decentralized platforms, the determination of lactate yet relies on discrete blood-based assays, which are invasive and inefficient and may cause tension and pain in the patient. Herein, we demonstrate the potential of a fully integrated microneedle (MN) sensing system for the minimally invasive...
What problem does this paper attempt to address?
### Problems the Paper Aims to Solve
This paper aims to develop a subcutaneous lactate monitoring system based on a microneedle (MN) sensor patch to improve the accuracy of in vivo detection. Specifically, the study attempts to address the following issues:
1. **Invasiveness and Efficiency Issues**:
- Current lactate measurement primarily relies on discrete blood testing methods, which are invasive, inefficient, and may cause anxiety and pain for patients.
- Existing point-of-care testing (POCT) methods, while reducing response time, still require blood sampling and can only provide discrete time-point measurements.
2. **Need for Real-time Continuous Monitoring**:
- Real-time monitoring of lactate levels and their fluctuations is crucial in managing infection-related symptoms (such as sepsis, malaria, dengue fever, etc.) and other non-infectious diseases (such as heart failure, trauma, surgery, etc.).
- There is a need for a non-invasive, user-friendly, reliable wearable lactate sensor that can provide continuous, real-time monitoring in various clinical settings.
3. **Limitations of Existing Technologies**:
- Currently reported lactate microneedle sensors have deficiencies in detection range, sensitivity, stability, and durability, especially performing poorly in high-concentration lactate detection.
- Most existing microneedle sensor studies remain at the in vitro stage, lacking sufficient in vivo validation, particularly in correlation with blood lactate levels.
### Solution
To address the above issues, this paper develops a novel microneedle sensor patch with the following main features:
1. **Uniform Coating Diffusion Limiting Layer**:
- By optimizing the multilayer structure, the sensor achieves full-range lactate detection (linear response range: 0.25−35 mM) and maintains stable operation for up to 8 hours.
2. **Dual Validation**:
- Through both in vitro and in vivo experiments, dual validation based on interstitial fluid (ISF) and blood measurements ensures detection accuracy.
3. **Monitoring Lactate Level Fluctuations under Anesthesia**:
- Simulating clinical scenarios, the sensor monitors lactate level changes under anesthesia, verifying its reliability in practical applications.
4. **Integrated Portable Device**:
- A fully integrated portable sensing device, including a wearable patch and a smartphone application, is designed and manufactured to enable rapid, routine, continuous, real-time lactate monitoring.
### Main Advantages
1. **Selectivity, Reversibility, Stability, and Durability**:
- The sensor ensures selectivity, reversibility, stability, and durability through a two-electrode amperometric readout.
2. **Accuracy and Reliability**:
- Both in vitro tests and in vivo measurements indicate that the sensor has high accuracy and reliability in measuring lactate levels.
3. **Broad Application Prospects**:
- This platform has significant advantages in various clinical settings, especially where laboratory services are limited or blood sampling is unsuitable, providing personalized medical services.
In summary, the microneedle sensor patch developed in this paper offers a new solution for real-time continuous lactate monitoring and is expected to play an important role in various clinical application scenarios.